103 related articles for article (PubMed ID: 31038623)
1. Comparative assessment of the replication efficiency of dengue, yellow fever, and chikungunya arboviruses in some insect and mammalian cell lines.
Guerrero NAS; Bello FJ
Rev Soc Bras Med Trop; 2019 Apr; 52():e20180511. PubMed ID: 31038623
[TBL] [Abstract][Full Text] [Related]
2. Infection of Mosquito Cells (C6/36) by Dengue-2 Virus Interferes with Subsequent Infection by Yellow Fever Virus.
Abrao EP; da Fonseca BA
Vector Borne Zoonotic Dis; 2016 Feb; 16(2):124-30. PubMed ID: 26808727
[TBL] [Abstract][Full Text] [Related]
3. Stress granule components G3BP1 and G3BP2 play a proviral role early in Chikungunya virus replication.
Scholte FE; Tas A; Albulescu IC; Žusinaite E; Merits A; Snijder EJ; van Hemert MJ
J Virol; 2015 Apr; 89(8):4457-69. PubMed ID: 25653451
[TBL] [Abstract][Full Text] [Related]
4. Development of multiplex real-time reverse-transcriptase polymerase chain reaction assay for simultaneous detection of Zika, dengue, yellow fever, and chikungunya viruses in a single tube.
Wu W; Wang J; Yu N; Yan J; Zhuo Z; Chen M; Su X; Fang M; He S; Zhang S; Zhang Y; Ge S; Xia N
J Med Virol; 2018 Nov; 90(11):1681-1686. PubMed ID: 29979812
[TBL] [Abstract][Full Text] [Related]
5. Competitive suppression between chikungunya and dengue virus in Aedes albopictus c6/36 cell line.
Potiwat R; Komalamisra N; Thavara U; Tawatsin A; Siriyasatien P
Southeast Asian J Trop Med Public Health; 2011 Nov; 42(6):1388-94. PubMed ID: 22299407
[TBL] [Abstract][Full Text] [Related]
6. Dengue-2 and yellow fever 17DD viruses infect human dendritic cells, resulting in an induction of activation markers, cytokines and chemokines and secretion of different TNF-α and IFN-α profiles.
Gandini M; Reis SR; Torrentes-Carvalho A; Azeredo EL; Freire Mda S; Galler R; Kubelka CF
Mem Inst Oswaldo Cruz; 2011 Aug; 106(5):594-605. PubMed ID: 21894381
[TBL] [Abstract][Full Text] [Related]
7. Co-Infection of Mosquitoes with Chikungunya and Dengue Viruses Reveals Modulation of the Replication of Both Viruses in Midguts and Salivary Glands of Aedes aegypti Mosquitoes.
Le Coupanec A; Tchankouo-Nguetcheu S; Roux P; Khun H; Huerre M; Morales-Vargas R; Enguehard M; Lavillette D; Missé D; Choumet V
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28777313
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of Dengue and Yellow Fever viruses by heme, cobalt-protoporphyrin IX and tin-protoporphyrin IX.
Assunção-Miranda I; Cruz-Oliveira C; Neris RL; Figueiredo CM; Pereira LP; Rodrigues D; Araujo DF; Da Poian AT; Bozza MT
J Appl Microbiol; 2016 Mar; 120(3):790-804. PubMed ID: 26759117
[TBL] [Abstract][Full Text] [Related]
9. The polypyrimidine tract-binding protein is required for efficient dengue virus propagation and associates with the viral replication machinery.
Anwar A; Leong KM; Ng ML; Chu JJH; Garcia-Blanco MA
J Biol Chem; 2009 Jun; 284(25):17021-17029. PubMed ID: 19380576
[TBL] [Abstract][Full Text] [Related]
10. Chikungunya virus induces a more moderate cytopathic effect in mosquito cells than in mammalian cells.
Li YG; Siripanyaphinyo U; Tumkosit U; Noranate N; A-nuegoonpipat A; Tao R; Kurosu T; Ikuta K; Takeda N; Anantapreecha S
Intervirology; 2013; 56(1):6-12. PubMed ID: 22907160
[TBL] [Abstract][Full Text] [Related]
11. New approaches for the standardization and validation of a real-time qPCR assay using TaqMan probes for quantification of yellow fever virus on clinical samples with high quality parameters.
Fernandes-Monteiro AG; Trindade GF; Yamamura AM; Moreira OC; de Paula VS; Duarte AC; Britto C; Lima SM
Hum Vaccin Immunother; 2015; 11(7):1865-71. PubMed ID: 26011746
[TBL] [Abstract][Full Text] [Related]
12. Mosquito and mammalian cells grown on microcarriers for four-serotype dengue virus production: variations in virus titer, plaque morphology, and replication rate.
Liu CC; Wu SC
Biotechnol Bioeng; 2004 Mar; 85(5):482-8. PubMed ID: 14760688
[TBL] [Abstract][Full Text] [Related]
13. RPLP1 and RPLP2 Are Essential Flavivirus Host Factors That Promote Early Viral Protein Accumulation.
Campos RK; Wong B; Xie X; Lu YF; Shi PY; Pompon J; Garcia-Blanco MA; Bradrick SS
J Virol; 2017 Feb; 91(4):. PubMed ID: 27974556
[TBL] [Abstract][Full Text] [Related]
14. Loss of Glycosaminoglycan Receptor Binding after Mosquito Cell Passage Reduces Chikungunya Virus Infectivity.
Acharya D; Paul AM; Anderson JF; Huang F; Bai F
PLoS Negl Trop Dis; 2015; 9(10):e0004139. PubMed ID: 26484530
[TBL] [Abstract][Full Text] [Related]
15. Arbovirus investigation in patients from Mato Grosso during Zika and Chikungunya virus introdution in Brazil, 2015-2016.
de Souza Costa MC; Siqueira Maia LM; Costa de Souza V; Gonzaga AM; Correa de Azevedo V; Ramos Martins L; Chavez Pavoni JH; Gomes Naveca F; Dezengrini Slhessarenko R
Acta Trop; 2019 Feb; 190():395-402. PubMed ID: 30552880
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of dengue virus infection by small interfering RNAs that target highly conserved sequences in the NS4B or NS5 coding regions.
Villegas PM; Ortega E; Villa-Tanaca L; Barrón BL; Torres-Flores J
Arch Virol; 2018 May; 163(5):1331-1335. PubMed ID: 29392497
[TBL] [Abstract][Full Text] [Related]
17. MEK/ERK activation plays a decisive role in yellow fever virus replication: implication as an antiviral therapeutic target.
Albarnaz JD; De Oliveira LC; Torres AA; Palhares RM; Casteluber MC; Rodrigues CM; Cardozo PL; De Souza AM; Pacca CC; Ferreira PC; Kroon EG; Nogueira ML; Bonjardim CA
Antiviral Res; 2014 Nov; 111():82-92. PubMed ID: 25241249
[TBL] [Abstract][Full Text] [Related]
18. Infection of epithelial cells with dengue virus promotes the expression of proteins favoring the replication of certain viral strains.
Martínez-Betancur V; Marín-Villa M; Martínez-Gutierrez M
J Med Virol; 2014 Aug; 86(8):1448-58. PubMed ID: 24374781
[TBL] [Abstract][Full Text] [Related]
19. LSm1 binds to the Dengue virus RNA 3' UTR and is a positive regulator of Dengue virus replication.
Dong Y; Yang J; Ye W; Wang Y; Miao Y; Ding T; Xiang C; Lei Y; Xu Z
Int J Mol Med; 2015 Jun; 35(6):1683-9. PubMed ID: 25872476
[TBL] [Abstract][Full Text] [Related]
20. Current status, challenges and perspectives in the development of vaccines against yellow fever, dengue, Zika and chikungunya viruses.
Silva JVJ; Lopes TRR; Oliveira-Filho EF; Oliveira RAS; Durães-Carvalho R; Gil LHVG
Acta Trop; 2018 Jun; 182():257-263. PubMed ID: 29551394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
